Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06601530Phase 4Completed
Phase 4, randomised, double-blind trial, sponsored by Istanbul University-Cerrahpaşa. Primary endpoints: Numeric Rating Scale at rest at 24 hours and Numeric Rating Scale during coughing at 24 hours. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06601530.